• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    DuPont Announces Agreement to Divest Aramids Business to Arclin

    8/29/25 6:55:00 AM ET
    $DD
    Major Chemicals
    Industrials
    Get the next $DD alert in real time by email
    • Transaction structure maximizes shareholder value, enables participation in future upside potential of combined new entity
    • Divestiture further streamlines the new DuPont portfolio and improves its financial profile

    WILMINGTON, Del., Aug. 29, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that Arclin, a portfolio company of an affiliate of TJC, L.P. (TJC), has reached a definitive agreement to acquire DuPont's Aramids business (Kevlar® and Nomex®) in a transaction valuing the business at approximately $1.8 billion.

    DuPont Logo (PRNewsfoto/DuPont)

    Arclin has received fully committed financing in connection with the transaction, which is expected to close in the first quarter of 2026, subject to customary closing conditions and regulatory approval.

    At close, DuPont will receive pre-tax cash proceeds of approximately $1.2 billion, subject to customary transaction adjustments, a note receivable of $300 million, and a non-controlling common equity interest in the future Arclin company currently valued at $325 million, which is expected to represent an approximate 17.5% stake at the time of close.

    "Today's announcement is another important step in our continued optimization of the new DuPont portfolio," said Lori Koch, DuPont Chief Executive Officer. "The Aramids transaction further enhances the strategic focus of our portfolio, while also increasing the growth and margin profile. The transaction is structured to maximize value for our shareholders by providing significant cash proceeds at close which will be re-deployed to further drive value creation, while also allowing DuPont shareholders to participate in Arclin's growth potential through our retained equity interest," continued Koch.

    "We are excited to partner again with TJC given their successful track record of creating value through an operations-focused approach and are confident in their ability to drive growth and opportunity for the employees and customers of the combined businesses," Koch concluded. 

    "The addition of Kevlar® and Nomex® to the Arclin portfolio presents a unique opportunity to transform our business with increased scale, broader global reach, and market-leading application development capabilities. The growth potential this acquisition presents will allow us to double down on our commitment to bringing impactful solutions and products to market, such as Arclin Firepoint, that protect what matters most," said Bradley Bolduc, Arclin's President and Chief Executive Officer. "We are excited about the endless opportunities ahead of us with these businesses in our portfolio." 

    The Aramids business is the inventor and largest global producer of industry-leading high performance synthetic fibers that protect people, equipment and structures in high cost-of-failure applications. Aramids' synthetic fibers, Kevlar® and Nomex®, are well-known brands globally with a longstanding reputation for quality, product performance and supply reliability. With about 1,900 employees and five manufacturing sites, the Aramids business generated net sales of $1.3 billion in 2024.

    The Aramids divestiture will not impact DuPont's intended separation of its electronics business (Qnity), which remains on track for a November 1, 2025 spin-off.

    Centerview Partners and Goldman Sachs & Co. LLC and are serving as DuPont's financial advisor and Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal counsel. Piper Sandler & Company is serving as financial advisor and Kirkland & Ellis LLP is serving as legal counsel to TJC/Arclin.

    About Arclin

    Arclin is a leading materials science company and manufacturer of polymer technologies, engineered products and specialized materials for the construction, agriculture, transportation infrastructure, weather & fire protection, pharmaceutical, nutrition, electronics, design, and other industries. Headquartered in Alpharetta, Georgia, Arclin has offices and manufacturing facilities throughout the U.S., Canada, and U.K. and manufactures for customers worldwide. For more information, visit www.arclin.com.

    About TJC

    TJC, L.P., formerly known as The Jordan Company, has worked for more than 40 years with CEOs, founders and entrepreneurs across a range of industries including Diversified Industrials, Industrial Technology, Consumer & Healthcare, Logistics & Supply Chain and Technology & Infrastructure. With $33.2 billion of assets under management as of June 30, 2025, TJC is managed by a senior leadership team that has invested together for over 23 years on over 85 investments. TJC has offices in New York, Chicago, Miami and Stamford. For more information, please visit www.tjclp.com.

    About DuPont

    DuPont (NYSE:DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

    For further information:

    DuPont Investors:  

    Ann Giancristoforo  

    [email protected] 

    +1 989-294-5890  

    Ed Barna

    [email protected]

    +1 302-596-6050

    Media:

    Dan Turner

    [email protected]

    +1 302-299-7628

    DuPontTM and all products, unless otherwise noted, denoted with TM, SM or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.

    Cautionary Statement Regarding Forward-Looking Statements

    This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target, "outlook," "stabilization," "confident," "preliminary," "initial," and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance, including with respect to the potential impact of tariffs and discussion of trade sensitivity and macroeconomic uncertainties.  Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements.

    Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) the ability of DuPont to effect the Intended Electronics Separation and to meet the conditions related thereto; (ii) the possibility that the Intended Electronics Separation will not be completed within the anticipated time period or at all; (iii) the possibility that the Intended Electronics Separation will not achieve its intended benefits; (iv) the impact of Intended Electronics Separation on DuPont's businesses and the risk that the separation may be more difficult, time-consuming or costly than expected, including the impact on DuPont's resources, systems, procedures and controls, diversion of management's attention and the impact and possible disruption of existing relationships with customers, suppliers, employees and other business counterparties; (v) the possibility of disruption, including disputes, litigation or unanticipated costs, in connection with the Intended Electronics Separation; (vi) the uncertainty of the expected financial performance of DuPont or the separated company following completion of the Intended Electronics Separation; (vii) negative effects of the announcement or pendency of the Intended Electronics Separation on the market price of DuPont's securities and/or on the financial performance of DuPont; (viii) the ability to achieve anticipated capital structures in connection with Intended Electronics Separation, including the future availability of credit and factors that may affect such availability; (ix) the ability to achieve anticipated credit ratings in connection with the Intended Electronics Separation; (x) the ability to achieve anticipated tax treatments in connection with the Intended Electronics Separation and completed and future, if any, divestitures, mergers, acquisitions and other portfolio changes and the impact of changes in relevant tax and other laws; (xi)  the ability to timely effect, if at all, the  Aramids divestiture to Arclin, a  TJC LP company, and the impact of the Aramids divestiture and ownership of a minority interest, estimated to be 17.5%, in the future Arclin company on DuPont's results of operations;  (xii) risks and costs related to each of the parties respective performance under and the impact of the arrangement to share future eligible PFAS costs by and among DuPont, Corteva and Chemours, including the outcome of any pending or future litigation related to PFAS or PFOA, including personal injury claims and natural resource damages claims; the extent and cost of ongoing remediation obligations and potential future remediation obligations; and changes in laws and regulations applicable to PFAS chemicals; (xiii) indemnification of certain legacy liabilities; (xiv) the failure to realize expected benefits and effectively manage and achieve anticipated synergies and operational efficiencies in connection with the Intended Electronics Separation and completed and future, if any, divestitures, mergers, acquisitions, and other portfolio management, productivity and infrastructure actions; (xv) the risks and uncertainties, including increased costs and the ability to obtain raw materials and meet customer needs from, among other events, pandemics and responsive actions; (xvi) adverse changes in worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions; and other factors beyond DuPont's control, including inflation, recession, military conflicts, natural and other disasters or weather-related events, that impact the operations of DuPont, its customers and/or its suppliers; (xvii) the ability to offset increases in cost of inputs, including raw materials, energy and logistics; (xviii) the risks associated with continuing or expanding trade disputes or restrictions and responsive actions, new or increased tariffs or export controls including on exports to China of U.S.-regulated products and technology, and the significant uncertainties related thereto; (xix) the risks, including ability to achieve, and costs associated with DuPont's sustainability strategy, including the actual conduct of DuPont's activities and results thereof, and the development, implementation, achievement or continuation of any goal, program, policy or initiative discussed or expected; (xx) other risks to DuPont's business and operations, including the risk of impairment; and (xxi) other risk factors discussed in DuPont's most recent annual report and subsequent current and periodic reports filed with the U.S. Securities and Exchange Commission. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont's consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-announces-agreement-to-divest-aramids-business-to-arclin-302541936.html

    SOURCE DuPont

    Get the next $DD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DD

    DatePrice TargetRatingAnalyst
    7/3/2025$75.00 → $85.00Buy
    Citigroup
    4/15/2025$75.00Underperform → Neutral
    BofA Securities
    4/14/2025$81.00Sector Weight → Overweight
    KeyBanc Capital Markets
    2/13/2025$85.00 → $89.00Underweight → Equal Weight
    Barclays
    1/17/2025$91.00Peer Perform → Outperform
    Wolfe Research
    10/7/2024$88.00 → $84.00Equal Weight → Underweight
    Barclays
    5/28/2024$85.00 → $95.00Neutral → Buy
    Citigroup
    5/24/2024$80.00 → $103.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $DD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup reiterated coverage on DuPont with a new price target

    Citigroup reiterated coverage of DuPont with a rating of Buy and set a new price target of $85.00 from $75.00 previously

    7/3/25 9:18:04 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont upgraded by BofA Securities with a new price target

    BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00

    4/15/25 8:43:17 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded DuPont from Sector Weight to Overweight and set a new price target of $81.00

    4/14/25 8:04:47 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dawnsens New-Materials Co. Voluntarily Consents to Order Prohibiting the Importation of Flashspun Nonwoven Materials into the United States

    WILMINGTON, Del., Sept. 8, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that the International Trade Commission (ITC) approved Dawnsens New-Materials Co. ("Dangs") voluntary agreement to a consent order which excludes Dangs from selling and importing into the United States all accused materials and products containing such materials for a period of 10 years. This decision concludes DuPont's litigation against Dangs at the ITC for the misappropriation of trade secrets related to DuPont's Tyvek® products.  The ITC is an independent, non-partisan agency responsible for i

    9/8/25 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont and Qnity to Webcast Investor Days

    WILMINGTON, Del., Sept. 3, 2025 /PRNewswire/ -- On Thursday, September 18, 2025 starting at 9:00 a.m.  ET, DuPont (NYSE:DD) will host a live video webcast of its Investor Day introducing the future DuPont company after the intended separation of Qnity Electronics, Inc. ("Qnity")*. Also on Thursday, September 18, 2025, starting at 2:00 p.m. ET, Qnity will host a live video webcast of its Investor Day introducing the future standalone, public company. Both Investor Days will include management presentations and a Q&A session. The real-time webcast of the DuPont Investor Day will

    9/3/25 4:00:00 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Announces Commencement of Exchange Offers and Consent Solicitations for Senior Notes

    WILMINGTON, Del., Sept. 2, 2025 /PRNewswire/ -- DuPont de Nemours, Inc. (NYSE:DD) ("DuPont") announced today the commencement of offers to exchange any and all of its outstanding senior notes of the series listed in the table below (the "Existing Notes") for new notes to be issued by DuPont (the "New Notes"). As previously disclosed, DuPont has announced that its Board of Directors has decided to pursue a separation of its electronics business, which includes its semiconductor technologies and interconnect solutions businesses, into an independent public company, Qnity Electronics, Inc. (the "Intended Electronics Separation"). The Intended Electronics Separation is targeted for completion on

    9/2/25 5:41:00 PM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP & CIO Larrabee Steven P. exercised 25,000 shares at a strike of $66.06 and sold $2,380,500 worth of shares (31,000 units at $76.79), decreasing direct ownership by 12% to 42,585 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    9/9/25 7:20:45 AM ET
    $DD
    Major Chemicals
    Industrials

    Director Lowery Frederick M. was granted 504 shares, increasing direct ownership by 2% to 33,270 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    9/3/25 5:18:23 PM ET
    $DD
    Major Chemicals
    Industrials

    Director Cutler Alexander M was granted 650 shares, increasing direct ownership by 0.89% to 73,879 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    9/3/25 5:17:32 PM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    SEC Filings

    View All

    SEC Form 8-K filed by DuPont de Nemours Inc.

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    9/2/25 6:05:30 AM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form 8-K filed by DuPont de Nemours Inc.

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    8/29/25 7:09:50 AM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form 8-K filed by DuPont de Nemours Inc.

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    8/15/25 4:25:21 PM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Leadership Updates

    Live Leadership Updates

    View All

    DuPont Announces Appointment of Kurt McMaken to Board of Directors

    WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of Kurt McMaken to its Board of Directors, effective immediately. Mr. McMaken will serve on the Audit committee and Nomination and Governance committee. "We are pleased to welcome Kurt to DuPont's Board of Directors," said DuPont Executive Chairman Ed Breen. "Kurt's global business expertise in the manufacturing sector and extensive background in finance and strategic planning make him well suited to help guide DuPont's growth and value creation strategies. We look forward to his c

    2/21/25 4:15:00 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Announces Two Technology Leaders as DuPont Laureates

    Dr. Deyan Wang and Nicholas Sands Recognized for a Career of Innovation and Business Impact; Achieve Highest Technical Level in the Company WILMINGTON, Del., Oct. 10, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced that two of its technology leaders have achieved the professional distinction of DuPont Laureate, the company's most distinguished technical designation. The newly appointed Laureates are Dr. Deyan Wang, DuPont Electronics & Industrial and Nicholas (Nick) Sands of DuPont Water & Protection. "I'm tremendously honored to recognize Deyan and Nick, two of DuPont's

    10/10/24 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont to Acquire Donatelle Plastics Incorporated

    Transaction deepens healthcare offerings in medical device solutions WILMINGTON, Del., June 25, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has signed an agreement to acquire Donatelle Plastics Incorporated, a leading medical device contract manufacturer specializing in the design, development and manufacture of medical components and devices. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. "Our healthcare strategy is focused on offering a comprehensive sui

    6/25/24 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Financials

    Live finance-specific insights

    View All

    DuPont Reports Second Quarter 2025 Results

    Net Sales of $3.3 billion increased 3%; organic sales increased 2% versus year-ago periodGAAP Income from continuing operations of $238 million; operating EBITDA of $859 millionGAAP EPS from continuing operations of $0.54; adjusted EPS of $1.12Cash provided by operating activities from continuing operations of $381 million; transaction- adjusted free cash flow of $433 millionFull year 2025 guidance raised on stronger second quarter performanceWILMINGTON, Del., Aug. 5, 2025 /PRNewswire/ -- DuPont (NYSE:DD) announced its financial results(1) for the second quarter ended June 30, 2025.

    8/5/25 6:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Schedules Second Quarter 2025 Earnings Conference Call

    WILMINGTON, Del., July 22, 2025 /PRNewswire/ -- DuPont (NYSE:DD) will release its second quarter financial results at 6:00 a.m. ET on Tuesday, August 5, 2025. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website.        The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5994046. About D

    7/22/25 4:15:00 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Publishes 2025 Sustainability Report

    Report highlights strong progress on 2030 Sustainability Goals focused on value creation and risk reduction, with significant achievements on climate action WILMINGTON, Del., July 22, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today published its 2025 Sustainability Report detailing the progress made toward achieving its 2030 Sustainability Goals. "At DuPont, innovation and sustainability are deeply interconnected—and that's reflected in the strong results we've delivered," said Lori Koch, DuPont Chief Executive Officer. "This past year, our teams advanced breakthrough technologies

    7/22/25 8:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DuPont de Nemours Inc.

    SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

    11/12/24 11:54:03 AM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by DuPont de Nemours Inc. (Amendment)

    SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

    2/13/24 4:55:53 PM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by DuPont de Nemours Inc.

    SC 13G - DuPont de Nemours, Inc. (0001666700) (Subject)

    2/9/24 11:49:03 AM ET
    $DD
    Major Chemicals
    Industrials